Fig. 3
From: Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation
Identification of putative Siglec-E ligands by proximity labeling method. a Schematic overview of the procedure to identify Siglec-E ligands. b Western blot analysis of biotinylated proteins in cell lysates and affinity-purified fraction. c The list of identified CD36 peptides. Protein abundance ratio was calculated from the median of peptide ratios. d The Quantification Spectrum of selected peptide (EVVLEEGTTAFK) of CD36